{"count": 2, "results": [{"_id": "32360359", "pmid": 32360359, "title": "Metformin inhibits the activation of melanocortin receptors 2 and 3 in vitro: A possible mechanism for its anti-androgenic and weight balancing effects in vivo?", "journal": "J Steroid Biochem Mol Biol", "authors": ["Parween S", "Rihs S", "Flück CE"], "date": "2020-06-01T00:00:00Z", "doi": "10.1016/j.jsbmb.2020.105684", "meta_date_publication": "2020 Jun", "meta_volume": "200", "meta_issue": "", "meta_pages": "105684", "score": 50255.69, "text_hl": "Our study may explain how @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ helps in @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ and attenuates the excess response to @GENE_POMC @GENE_5443 @@@ACTH@@@ in androgen excess disorders such as @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ and @<m>DISEASE_Adrenal_Hyperplasia_Congenital</m> @DISEASE_MESH:D000312 @@@CAH@@@.", "citations": {"NLM": "Parween S, Rihs S, Flück CE. Metformin inhibits the activation of melanocortin receptors 2 and 3 in vitro: A possible mechanism for its anti-androgenic and weight balancing effects in vivo? J Steroid Biochem Mol Biol. 2020 Jun;200():105684. PMID: 32360359", "BibTeX": "@article{32360359, title={Metformin inhibits the activation of melanocortin receptors 2 and 3 in vitro: A possible mechanism for its anti-androgenic and weight balancing effects in vivo?}, author={Parween S and Rihs S and Flück CE}, journal={J Steroid Biochem Mol Biol}, volume={200}, pages={105684}}"}}, {"_id": "18996819", "pmid": 18996819, "title": "Metformin-responsive classic salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case report.", "journal": "Endocr Pract", "authors": ["Mapas-Dimaya AC", "Agdere L", "Bahtiyar G", "Mejia JO", "Sacerdote AS"], "date": "2008-10-01T00:00:00Z", "doi": "10.4158/EP.14.7.889", "meta_date_publication": "2008 Oct", "meta_volume": "14", "meta_issue": "7", "meta_pages": "889-91", "score": 50061.84, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-responsive classic @<m>DISEASE_Adrenal_Hyperplasia_Congenital</m> @DISEASE_MESH:D000312 @@@salt-losing congenital adrenal hyperplasia@@@ due to @DISEASE_Congenital_adrenal_hyperplasia_due_to_21_hydroxylase_deficiency @DISEASE_MESH:C535979 @@@21-hydroxylase deficiency@@@: a case report.", "citations": {"NLM": "Mapas-Dimaya AC, Agdere L, Bahtiyar G, Mejia JO, Sacerdote AS. Metformin-responsive classic salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case report. Endocr Pract. 2008 Oct;14(7):889-91. PMID: 18996819", "BibTeX": "@article{18996819, title={Metformin-responsive classic salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case report.}, author={Mapas-Dimaya AC and Agdere L and Bahtiyar G and Mejia JO and Sacerdote AS}, journal={Endocr Pract}, volume={14}, number={7}, pages={889-91}}"}}]}